These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28747285)

  • 1. Awareness and screening attitudes of Portuguese dermatologists on cardiovascular risk factors in psoriatic patients.
    Raposo I; Bettencourt A; Selores M; Torres T
    Eur J Dermatol; 2017 Aug; 27(4):443-445. PubMed ID: 28747285
    [No Abstract]   [Full Text] [Related]  

  • 2. Obstacles and solutions to screening psoriasis patients for cardiovascular risk factors.
    Wang EC; Ker KJ; Chuah SY; Pan JY
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):819-23. PubMed ID: 23621681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoring.
    Boehncke WH
    J Rheumatol; 2014 Jun; 41(6):1224-6. PubMed ID: 24882857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and Cardiovascular Disease.
    Shahwan KT; Kimball AB
    Med Clin North Am; 2015 Nov; 99(6):1227-42. PubMed ID: 26476250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for depression and suicidality in psoriasis patients: A survey of US dermatologists.
    Liang SE; Cohen JM; Ho RS
    J Am Acad Dermatol; 2019 May; 80(5):1460-1462. PubMed ID: 30682396
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of trends and gaps in dermatologists' cardiovascular screening practices in psoriasis patients: Areas still in need of improvement.
    Manalo IF; Gilbert KE; Wu JJ
    J Am Acad Dermatol; 2015 Nov; 73(5):872-4.e4. PubMed ID: 26475543
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psoriasis and cardiovascular disease].
    Torres T; Sales R; Vasconcelos C; Selores M
    Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement.
    Abdulghani M; Al Sheik A; Alkhawajah M; Ammoury A; Behrens F; Benchikhi H; Benkaidali I; Doss N; El Gendy A; Mokhtar I; Odendaal D; Raboobee N; Thaçi D; Weiss R; Whitaker D
    J Int Med Res; 2011; 39(5):1573-88. PubMed ID: 22117959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patients with psoriasis have an increased risk of cardiovascular diseases].
    Ahlehoff O; Gislason G; Lindhardsen J; Skov L; Hansen PR
    Ugeskr Laeger; 2012 May; 174(21):1450-2. PubMed ID: 22640784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis: an opportunity to identify cardiovascular risk.
    Federman DG; Shelling M; Prodanovich S; Gunderson CG; Kirsner RS
    Br J Dermatol; 2009 Jan; 160(1):1-7. PubMed ID: 19016698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis and cardiovascular screening rates in the United States.
    Alamdari HS; Gustafson CJ; Davis SA; Huang W; Feldman SR
    J Drugs Dermatol; 2013 Jan; 12(1):e14-9. PubMed ID: 23377342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.
    Johnsson H; McInnes IB; Sattar N
    Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Performance Gaps in Comorbidity and Risk Factor Screening, Prevention, and Counseling Behaviors of Providers Caring for Children with Psoriasis.
    Swary JH; Stratman EJ
    Pediatr Dermatol; 2015; 32(6):813-8. PubMed ID: 26337861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion.
    Richard MA; Barnetche T; Horreau C; Brenaut E; Pouplard C; Aractingi S; Aubin F; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Ortonne JP; Paul C
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():2-11. PubMed ID: 23845148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
    Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
    J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tattooing and psoriasis: dermatologists' knowledge, attitudes and practices. An international study.
    Grodner C; Kluger N; Fougerousse AC; Cinotti E; Lacarrubba F; Quiles-Tsimaratos N; Mahé E;
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):e38-e40. PubMed ID: 29953677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.